Stem cells, and specifically mesenchymal stem cells (MSCs), have long been considered as a promising therapeutic agent for the treatment of a wide variety of degenerative and ischemic diseases. Over this time, MSC immunomodulation, their capacity for multilineage differentiation, and their ability to self-renew have been well established and are now considered to be clinically…
Osteoarthritis (OA) is the most common form of arthritis, affecting over 525 million people around the world. Characterized by pain, swelling, and stiffness resulting from the degradation of cartilage that provides cushion and protection between our bones, OA is an inflammatory condition without a clear and effective treatment. OA most commonly affects the hands, knees,…
Human Mesenchymal Stem Cells (hMSCs) are the non-hematopoietic, multipotent stem cells with the capacity to differentiate into mesodermal lineages such as osteocytes, adipocytes, and chondrocytes as well ectodermal (neurocytes) and endodermal lineages (hepatocytes). Until recently, when the immunomodulation properties of MSCs were proven to be clinically relevant, the use of these stem cells was met…
Mesenchymal stem cells (MSCs) have been widely studied and increasingly recognized as a potential therapeutic with the ability to initiate and support tissue regeneration and remodeling. While over 1100 clinical trials have been conducted to assess the therapeutic benefits of MSCs, there continues to be widespread variation surrounding the potential treatment outcomes associated with these…
Every year, stem cell therapy for multiple sclerosis gains massive traction due to its incredible regenerative and auto-repair properties. More specifically, patients who deal with chronic, incurable conditions such as multiple sclerosis (MS) are closely following any news about this cutting-edge technology. What is a stem cell? A stem cell is a special biological entity…
Multiple system atrophy (MSA) is a rare, degenerative adult-onset neurological disorder that affects your body's involuntary functions, including blood pressure, breathing, bladder function, and motor control. MSA also demonstrates several symptoms similar to those accompanying stem cell therapy for Parkinson disease’s disease, including slow movement, stiff muscles, and loss of balance[1]. Considering the rapid and…
Multiple sclerosis (MS) is a chronic inflammatory disease that attacks myelin, the protective sheath that covers nerves and causes progressive and serious communication issues between the brain, central nervous system, and the rest of the body[1]. Currently, it's estimated that over 2.3 million people worldwide, and over one million people in the US have a…
Regenerative medicine, also known as regenerative medicine, is emerging as a viable treatment for Parkinson’s disease as clinical trials move through the FDA approval process. Patients in clinical trials see positive results from mesenchymal regenerative medicine for Parkinson's Disease. What Is Parkinson’s Disease? Parkinson’s disease is a progressive, neurodegenerative condition. It occurs when dopamine-producing brain…
Articular cartilage, found on the surface of most regenerative medicine for musculoskeletal injuries joints, distributes and transfers forces between bones and joints, provides a smooth surface for joint mobility, and plays an important role in human mobility. However, articular cartilage is also easily susceptible to damage, but difficult to repair itself on its own (primarily…
Neurodegenerative conditions such as Alzheimer’s disease (AD), stem cell therapy for Parkinson disease’s disease (PD), and amyotrophic lateral sclerosis (ALS) occur when neuron populations begin to diminish. There is currently no cure for these types of diseases, though clinical trials to explore various treatment options are ongoing. In particular, regenerative medicine, also known as regenerative…
We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!